Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2020)
Cogent Biosciences (COGT) posted quarterly Asset Utilization Ratio of 0.04 for Q4 2020, down 90.39% year-over-year from 0.42 in Q1 2020, and down 85.13% quarter-over-quarter from 0.27 in Q3 2020.
Cogent Biosciences (COGT) Asset Utilization Ratio (2018 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has reported Asset Utilization Ratio for 3 consecutive years, with 0.04 the latest figure, recorded in Q4 2020.
- In Q4 2020, Asset Utilization Ratio fell 90.39% year-over-year to 0.04; the TTM figure through Dec 2020 stood at 0.04 (down 90.39% YoY), while the FY2020 annual figure was 0.05, down 84.23% from the prior year.
- Asset Utilization Ratio fell to 0.04 in Q4 2020 per COGT's latest filing, from 0.27 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.68 in Q2 2020 and bottomed at 0.04 in Q4 2020.
- Historically, Asset Utilization Ratio has averaged 0.25 across 3 years, with a median of 0.17 in 2019.
- On a YoY basis, Asset Utilization Ratio climbed as much as 374.14% in 2020 and fell as far as 90.39% in 2020.
- Cogent Biosciences' Asset Utilization Ratio stood at 0.11 in 2018, then jumped by 289.25% to 0.42 in 2019, then plunged by 90.39% to 0.04 in 2020.
- Business Quant data shows COGT's Asset Utilization Ratio at 0.04 in Q4 2020, 0.27 in Q3 2020, and 0.68 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 0.04 |
| Sep 30, 2020 | 0.27 |
| Jun 30, 2020 | 0.68 |
| Mar 31, 2020 | 0.60 |
| Dec 31, 2019 | 0.42 |
| Sep 30, 2019 | 0.17 |
| Jun 30, 2019 | 0.16 |
| Mar 31, 2019 | 0.13 |
| Dec 31, 2018 | 0.11 |
| Sep 30, 2018 | 0.08 |
| Jun 30, 2018 | 0.11 |
| Mar 31, 2018 | 0.19 |